Ana Batista to Prealbumin
This is a "connection" page, showing publications Ana Batista has written about Prealbumin.
Connection Strength
1.227
-
Batista AR, Gianni D, Ventosa M, Coelho AV, Almeida MR, Sena-Esteves M, Saraiva MJ. Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model. Gene Ther. 2014 Dec; 21(12):1041-50.
Score: 0.456
-
Batista AR, Sena-Esteves M, Saraiva MJ. Hepatic production of transthyretin L12P leads to intracellular lysosomal aggregates in a new somatic transgenic mouse model. Biochim Biophys Acta. 2013 Aug; 1832(8):1183-93.
Score: 0.411
-
Batista AR, Flotte TR. In?vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis. Mol Ther. 2021 09 01; 29(9):2633-2634.
Score: 0.184
-
Macedo B, Magalh?es J, Batista AR, Saraiva MJ. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol Res. 2010 Dec; 62(6):514-22.
Score: 0.085
-
Macedo B, Batista AR, Ferreira N, Almeida MR, Saraiva MJ. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy. Biochim Biophys Acta. 2008 Sep; 1782(9):517-22.
Score: 0.073
-
Macedo B, Batista AR, do Amaral JB, Saraiva MJ. Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Mol Med. 2007 Nov-Dec; 13(11-12):584-91.
Score: 0.018